This study involved 154 subjects with type 1 and type 2 diabetes (84.6% with type 1 diabetes, age 46.6 ±13.6 years; 52% female, A1c 8.3 ± 0.9 %) who were undergoing intensified insulin therapy. Participants completed a questionnaire (SMART) that measures the accuracy of estimating carbohydrates in 27 foods or in meals, using the multiple-choice method. At the same time, glucose data collected by a flash glucose monitoring system were analysed in the two weeks prior to completion of the SMART questionnaire. The level of estimation error regarding carbohydrates correlated significantly with glucose variability (CV; r=-0.29; p<0.001), range of glucose values (r=0.33, p<.001) and maximum glucose values (r=0.32, p<.001). These significant effects remained even after adjustment for HbA1c. Interestingly, there was no significant correlation between estimation error and mean glucose values (r=0.012, p=0.882), time in range (r=-0.018; p=0.815) or percentage of hyperglycemic (>180 mg/dl; r=0.015, p=0.843) or hypoglycemic phases (<70 mg/dl; r=0.005; p=0.953). The negative correlation coefficient indicates that underestimation of the amount of carbohydrates in a meal is more significant in terms of glucose variability than overestimation of the amount of carbohydrates. The results suggest that a good estimation ability regarding carbohydrate content is associated with lower glucose variability but does not necessarily affect glucose levels.

Disclosure

N. Hermanns: Advisory Panel; Self; Roche Diabetes Care. Research Support; Self; Abbott, AstraZeneca, Berlin-Chemie AG. D. Ehrmann: Speaker’s Bureau; Self; Abbott, Berlin-Chemie AG, Glooko, Inc. Other Relationship; Self; Dexcom, Inc., Roche Diabetes Care. B. Kulzer: Research Support; Self; Abbott, AstraZeneca, Berlin-Chemie AG, Roche Diabetes Care. Speaker’s Bureau; Self; Abbott, Ascensia Diabetes Care, Berlin-Chemie AG, Eli Lilly and Company, Medtronic, Novo Nordisk Inc., Roche Diabetes Care.

Funding

Abbott Diabetes Care Germany

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.